MEDAPP S.A. ZY -10 (WQ1) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MEDAPP S.A. ZY -10 (WQ1) has a cash flow conversion efficiency ratio of 0.076x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.04 Million ≈ $2.39 Million USD) by net assets (€26.82 Million ≈ $31.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see WQ1 market cap for the company's overall valuation and market capitalisation.
MEDAPP S.A. ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how MEDAPP S.A. ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data.
MEDAPP S.A. ZY -10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MEDAPP S.A. ZY -10 ranked by their cash flow conversion efficiency. Explore WQ1 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ENEFI Energiahatekonysagi Nyrt
BUD:ENEFI
|
-0.013x |
|
TGS Esports Inc
V:TGS
|
0.391x |
|
Woodlandor Holdings Bhd
KLSE:7025
|
-0.017x |
|
CGN Resources Ltd
AU:CGR
|
-0.393x |
|
Intelligent Living Application Group Inc
NASDAQ:ILAG
|
-0.142x |
|
Riedel Resources Ltd
AU:RIE
|
-0.041x |
|
Duta Pertiwi Nusantara Tbk
JK:DPNS
|
0.009x |
|
Craneware Plc
LSE:CRW
|
0.008x |
Annual Cash Flow Conversion Efficiency for MEDAPP S.A. ZY -10 (2021–2025)
The table below shows the annual cash flow conversion efficiency of MEDAPP S.A. ZY -10 from 2021 to 2025. View MEDAPP S.A. ZY -10 share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €26.82 Million ≈ $31.35 Million |
€2.44 Million ≈ $2.85 Million |
0.091x | -37.13% |
| 2024-12-31 | €28.84 Million ≈ $33.71 Million |
€4.17 Million ≈ $4.87 Million |
0.144x | +391.16% |
| 2023-12-31 | €26.73 Million ≈ $31.25 Million |
€-1.33 Million ≈ $-1.55 Million |
-0.050x | -123.57% |
| 2022-12-31 | €27.19 Million ≈ $31.79 Million |
€5.72 Million ≈ $6.69 Million |
0.210x | +1315.77% |
| 2021-12-31 | €25.25 Million ≈ $29.52 Million |
€-437.00K ≈ $-510.90K |
-0.017x | -- |
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D… Read more